Gradient Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3
Closed -$411 543
2024
Q2
$411 Hold
3
﹤0.01% 1208
2024
Q1
$399 Sell
3
-11
-79% -$1.43K ﹤0.01% 1046
2023
Q4
$1.93K Sell
14
-6
-30% -$789 ﹤0.01% 1239
2023
Q3
$2.44K Hold
20
﹤0.01% 1128
2023
Q2
$2.81K Buy
20
+7
+54% +$965 ﹤0.01% 1082
2023
Q1
$1.84K Sell
13
-1
-7% -$143 ﹤0.01% 1119
2022
Q4
$2.19K Sell
14
-55
-80% -$7.9K ﹤0.01% 1072
2022
Q3
$8K Buy
69
+46
+200% +$6.06K ﹤0.01% 843
2022
Q2
$3K Sell
23
-11
-32% -$1.5K ﹤0.01% 974
2022
Q1
$5K Hold
34
﹤0.01% 878
2021
Q4
$6K Sell
34
-10
-23% -$1.52K ﹤0.01% 895
2021
Q3
$6K Sell
44
-59
-57% -$8.63K ﹤0.01% 852
2021
Q2
$14K Sell
103
-25
-20% -$3.27K ﹤0.01% 697
2021
Q1
$16K Sell
128
-78,258
-100% -$9.64M ﹤0.01% 659
2020
Q4
$8.97M Sell
78,386
-1,163
-1% -$142K 0.38% 75
2020
Q3
$9.11M Sell
79,549
-15,493
-16% -$1.83M 0.38% 75
2020
Q2
$10.8M Buy
95,042
+94,977
+146,118% +$10.1M 0.49% 55
2020
Q1
$5K Hold
65
﹤0.01% 767
2019
Q4
$7K Buy
65
+59
+983% +$6.15K ﹤0.01% 760
2019
Q3
$1K Buy
+6
New +$616 ﹤0.01% 983
2015
Q2
Sell
-41
Closed -$3K 637
2015
Q1
$3K Hold
41
﹤0.01% 506
2014
Q4
$3K Buy
+41
New +$2.59K ﹤0.01% 455

Other funds holding DGX

Gradient Investments's DGX Position: Q3 2024 in Review

Gradient Investments sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 3 shares — an estimated $411 sold.

Gradient Investments first reported a position in DGX in Q4 2014 and held it in 22 quarters. The position peaked at $10.8M in Q2 2020. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • Gradient Investments reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 3 Quest Diagnostics shares in Q3 2024, an estimated $411.
  • Gradient Investments first reported a position in Quest Diagnostics in Q4 2014 and held it in 22 quarters.
  • Gradient Investments's Quest Diagnostics position peaked at $10.8M in Q2 2020.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.